Skip to Content

Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference

SAN DIEGO--(BUSINESS WIRE)--Apr 30, 2012 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:10 p.m. ET / 11:10 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.

The presentation will be webcast through the “Investors” section of Amylin's corporate website at, and a recording will be made available following the event. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin is committed to delivering novel therapies that transform the way diabetes and other metabolic disorders are treated. Amylin is headquartered in San Diego, Calif., and has a commercial manufacturing facility in Ohio. More information on Amylin Pharmaceuticals is available at

Contact: Amylin Pharmaceuticals, Inc.
Christine Everett-Zedelmayer
(858) 458-8517
Alice Izzo
(858) 642-7272


Posted: April 2012